Mandate

Vinge has advised Procuritas in connection with its investment in Strandberg Guitars

Vinge has advised Procuritas in connection with its investment in Strandberg Guitars, the global market leader in headless guitars under the .strandberg* brand.

Founded in 2012 by Ola Strandberg, Strandberg Guitars has established itself as the leading brand globally in headless guitars, a fast-growing niche in the electric guitar market. Headquartered in Uppsala, Sweden with local operations in California, USA the Company serves its global customer base directly online and through a wide network of renowned music retailers. Through its well-developed digital platform, Strandberg Guitars has built a large and highly engaged community of followers and musicians around the world. Since inception, the Company has had an uncompromised commitment to innovation aimed to lead the development of high-performance guitars that meet the needs of modern guitarists.

Vinge’s team consisted of, among others, Jonas Bergström, Jonas Johansson, Anna Jonsson, Carl Sander, Eléonore Friberg, Carl Trolle Olson and Alice Clarin (M&A), Lisa Hörnqvist, Karolina Fuhrman and Cecilia Cronqvist (Corporate Commercial and IT), Malin Malm Waerme and Arvid Axelryd (IP), Karin Gynnerstedt, Ebba Svenburg and Carl Östlund (Employment) and Erik Ax.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025